BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 1999498)

  • 1. Infantile form of carnitine palmitoyltransferase II deficiency with hepatomuscular symptoms and sudden death. Physiopathological approach to carnitine palmitoyltransferase II deficiencies.
    Demaugre F; Bonnefont JP; Colonna M; Cepanec C; Leroux JP; Saudubray JM
    J Clin Invest; 1991 Mar; 87(3):859-64. PubMed ID: 1999498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterisation of carnitine palmitoyltransferases in patients with a carnitine palmitoyltransferase deficiency: implications for diagnosis and therapy.
    Schaefer J; Jackson S; Taroni F; Swift P; Turnbull DM
    J Neurol Neurosurg Psychiatry; 1997 Feb; 62(2):169-76. PubMed ID: 9048718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Heterogeneity of carnitine palmitoyltransferase deficiencies. Deficiency of CPT I in the hepatic form and CPT II in the muscular form].
    Bonnefont JP; Ogier H; Mitchell G; Demaugre F; Pelet A; Saudubray JM; Frezal J
    Arch Fr Pediatr; 1985; 42 Suppl 1():613-7. PubMed ID: 4083994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation and biochemical analysis in carnitine palmitoyltransferase type II (CPT II) deficiency.
    Olpin SE; Afifi A; Clark S; Manning NJ; Bonham JR; Dalton A; Leonard JV; Land JM; Andresen BS; Morris AA; Muntoni F; Turnbull D; Pourfarzam M; Rahman S; Pollitt RJ
    J Inherit Metab Dis; 2003; 26(6):543-57. PubMed ID: 14605500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autopsy case of the neonatal form of carnitine palmitoyltransferase-II deficiency triggered by a novel disease-causing mutation del1737C.
    Semba S; Yasujima H; Takano T; Yokozaki H
    Pathol Int; 2008 Jul; 58(7):436-41. PubMed ID: 18577113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neonatal carnitine palmitoyltransferase II deficiency associated with Dandy-Walker syndrome and sudden death.
    Yahyaoui R; Espinosa MG; Gómez C; Dayaldasani A; Rueda I; Roldán A; Ugarte M; Lastra G; Pérez V
    Mol Genet Metab; 2011 Nov; 104(3):414-6. PubMed ID: 21641254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical varieties of carnitine and carnitine palmitoyltransferase deficiency.
    Angelini C; Trevisan C; Isaya G; Pegolo G; Vergani L
    Clin Biochem; 1987 Feb; 20(1):1-7. PubMed ID: 3552320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscle Carnitine Palmitoyltransferase II (CPT II) Deficiency: A Conceptual Approach.
    Joshi PR; Zierz S
    Molecules; 2020 Apr; 25(8):. PubMed ID: 32295037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New genetic defects in mitochondrial fatty acid oxidation and carnitine deficiency.
    Stanley CA
    Adv Pediatr; 1987; 34():59-88. PubMed ID: 3318304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central nervous system disorders and possible brain type carnitine palmitoyltransferase II deficiency.
    Ohtani Y; Tomoda A; Miike T; Matsukura M; Miyatake M; Narazaki O
    Brain Dev; 1994; 16(2):139-45. PubMed ID: 8048703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional analysis of iPSC-derived myocytes from a patient with carnitine palmitoyltransferase II deficiency.
    Yasuno T; Osafune K; Sakurai H; Asaka I; Tanaka A; Yamaguchi S; Yamada K; Hitomi H; Arai S; Kurose Y; Higaki Y; Sudo M; Ando S; Nakashima H; Saito T; Kaneoka H
    Biochem Biophys Res Commun; 2014 May; 448(2):175-81. PubMed ID: 24780397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscle Carnitine Palmitoyltransferase II Deficiency: A Review of Enzymatic Controversy and Clinical Features.
    Lehmann D; Motlagh L; Robaa D; Zierz S
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28054946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular basis of hepatic carnitine palmitoyltransferase I deficiency.
    IJlst L; Mandel H; Oostheim W; Ruiter JP; Gutman A; Wanders RJ
    J Clin Invest; 1998 Aug; 102(3):527-31. PubMed ID: 9691089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences between acylcarnitine profiles in plasma and bloodspots.
    de Sain-van der Velden MG; Diekman EF; Jans JJ; van der Ham M; Prinsen BH; Visser G; Verhoeven-Duif NM
    Mol Genet Metab; 2013; 110(1-2):116-21. PubMed ID: 23639448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carnitine palmitoyltransferase II (CPT II) deficiency responsible for refractory cardiac arrhythmias, acute multiorgan failure and early fatal outcome.
    Serra G; Antona V; Insinga V; Morgante G; Vassallo A; Placa S; Piro E; Salerno S; Schierz IAM; Gitto E; Giuffrè M; Corsello G
    Ital J Pediatr; 2024 Apr; 50(1):67. PubMed ID: 38616285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complementation analysis of carnitine palmitoyltransferase I and II defects.
    Slama A; Brivet M; Boutron A; Legrand A; Saudubray JM; Demaugre F
    Pediatr Res; 1996 Oct; 40(4):542-6. PubMed ID: 8888280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel mutation identified in carnitine palmitoyltransferase II deficiency.
    Yang BZ; Ding JH; Roe D; Dewese T; Day DW; Roe CR
    Mol Genet Metab; 1998 Feb; 63(2):110-5. PubMed ID: 9562964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular analysis of a patient with carnitine palmitoyltransferase II deficiency].
    Akanuma J; Wataya K; Matubara Y; Yamamoto T; Kira J; Narisawa K
    Rinsho Shinkeigaku; 1997 Jun; 37(6):532-5. PubMed ID: 9366186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disorders of lipid metabolism in muscle.
    Di Mauro S; Trevisan C; Hays A
    Muscle Nerve; 1980; 3(5):369-88. PubMed ID: 7421873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular analysis of carnitine palmitoyltransferase II deficiency with hepatocardiomuscular expression.
    Bonnefont JP; Taroni F; Cavadini P; Cepanec C; Brivet M; Saudubray JM; Leroux JP; Demaugre F
    Am J Hum Genet; 1996 May; 58(5):971-8. PubMed ID: 8651281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.